Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- Rocky Mountain Cancer Centers
- Study ID
- NCT01185132
- Phase
- PHASE3
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- accelerated partial breast irradiation - 3D-conformal planning — RADIATION38.5 Gy, 10 fractions over 5 days
- accelerated partial breast irradiation - IMRT planning — RADIATION38.5 Gy, 10 fractions over 5 days
Study Details
In the setting of radiotherapy as part of breast-conservation therapy for patients with early stage breast cancer, the novel planning and delivery method of intensity modulated radiotherapy is an effective and safe alternative to the commonly-used standard 3D-conformal external beam radiotherapy, spares more normal breast and lung tissue, and may lead to improved clinical outcomes.
Key Dates
- Start date
- Jul 31, 2009
- Status verified
- Jun 2014
- Primary completion
- Jul 31, 2018
- Completion
- Jul 31, 2028
Study Design
- Enrollment
- 660 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: IMRTIntensity modulated radiotherapy, 38.5 Gy, 10 fractions over 5 days
- Active Comparator: 3D-CRTThree dimensional conformal external radiotherapy, 38.5 Gy, 10 fractions over 5 days
Primary Outcome Measure
Prevalence of breast pain after Accelerated Partial Breast Radiotherapy (APBI) [ Time Frame: 5 years ]
Central Contacts
- Rachel Lei, BS303-418-7607
- Charles Leonard, MD303-730-4700
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Rocky Mountain Cancer Centers - Aurora | Aurora | Colorado | 80012 | Dennis Carter, MD (SUB_INVESTIGATOR) William Daniel, MD (SUB_INVESTIGATOR) Kathryn Howell, MD (SUB_INVESTIGATOR) |
| Rocky Mountain Cancer Centers - Boulder | Boulder | Colorado | 80303 | Andrew Antell, MD (SUB_INVESTIGATOR) Meera Patel, MD (SUB_INVESTIGATOR) Ralph Wright, MD (SUB_INVESTIGATOR) |
| Rocky Mountain Cancer Centers - Lakewood | Lakewood | Colorado | 80228 | Ralph Wright, MD (SUB_INVESTIGATOR) Charles Leonard, MD (PRINCIPAL_INVESTIGATOR) |
| Rocky Mountain Cancer Centers - Littleton | Littleton | Colorado | 80120 | Charles Leonard, MD (PRINCIPAL_INVESTIGATOR) Kathryn Howell, MD (SUB_INVESTIGATOR) |
| Rocky Mountain Cancer Centers - Thornton | Thornton | Colorado | 80260 | Robert LaPorte, MD (SUB_INVESTIGATOR) Daniel Chin, MD (SUB_INVESTIGATOR) |
Find similar trials in Aurora, CO
By condition
By specialty
Related Studies
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- The Immune System's Response to Young Women's Breast CancerRecruiting · University of Colorado, Denver · Aurora, Colorado
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression ProfilesRecruiting · Agendia · Birmingham, Alabama